Active Ingredient: DICLOFENAC SODIUM
Proprietary Name: DYLOJECT
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 37.5MG/ML (37.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N022396
Product Number: 001
Approval Date: Dec 23, 2014
Applicant Holder Full Name: JAVELIN PHARMACEUTICALS INC A WHOLLY OWNED SUDSIDIARY OF HOSPIRA INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
